SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Chien-Hsin Chang, Tur-Fu Huang, Kung-Tin Lin, Chun-Chieh Hsu, Wei-Luen Chang, Shih-Wei Wang, Feng-Nien Ko, Hui-Chin Peng, Ching-Hu Chung, 4-Acetylantroquinonol B Suppresses Tumor Growth and Metastasis of Hepatoma Cells via Blockade of Translation-Dependent Signaling Pathway and VEGF Production, Journal of Agricultural and Food Chemistry, 2015, 63, 1, 208

    CrossRef

  2. 2
    Jianlin Wang, Xisheng Yang, Bai Ruan, Bin Dai, Yuan Gao, Juanli Duan, Shibin Qu, Kaishan Tao, Kefeng Dou, Haimin Li, Overexpression of miR-200a suppresses epithelial-mesenchymal transition of liver cancer stem cells, Tumor Biology, 2014,

    CrossRef

  3. 3
    Lei Sun, Tao Li, Qing Wei, Ying Zhang, Xiaoqing Jia, Zhengkun Wan, Lihui Han, Upregulation of BNIP3 mediated by ERK/HIF-1α pathway induces autophagy and contributes to anoikis resistance of hepatocellular carcinoma cells, Future Oncology, 2014, 10, 8, 1387

    CrossRef

  4. 4
    Yun-Hsuan Lee, Chia-Yang Hsu, Cheng-Yuan Hsia, Yi-Hsiang Huang, Chien-Wei Su, Yi-You Chiou, Han-Chieh Lin, Teh-Ia Huo, Shou-Dong Lee, Alcoholism worsens the survival of patients with hepatitis B virus and C virus-related hepatocellular carcinoma, Hepatology International, 2013, 7, 2, 645

    CrossRef

  5. 5
    Chia-Yang Hsu, Yun-Hsuan Lee, Yi-Hsiang Huang, Cheng-Yuan Hsia, Chien-Wei Su, Han-Chieh Lin, Rheun-Chuan Lee, Yi-You Chiou, Fa-Yauh Lee, Teh-Ia Huo, Shou-Dong Lee, Ascites in patients with hepatocellular carcinoma: prevalence, associated factors, prognostic impact, and staging strategy, Hepatology International, 2013, 7, 1, 188

    CrossRef

  6. 6
    Hyung Joon Kim, Hyun Woong Lee, Important predictor of mortality in patients with end-stage liver disease, Clinical and Molecular Hepatology, 2013, 19, 2, 105

    CrossRef

  7. 7
    Chin-Sheng Hung, Hui-Hsiung Liu, Jun-Jen Liu, Chi-Tai Yeh, Tung-Cheng Chang, Chih-Hsiung Wu, Yuan-Soon Ho, Po-Li Wei, Yu-Jia Chang, MicroRNA-200a and -200b Mediated Hepatocellular Carcinoma Cell Migration Through the Epithelial to Mesenchymal Transition Markers, Annals of Surgical Oncology, 2013, 20, S3, 360

    CrossRef

  8. 8
    Chia-Yang Hsu, Yun-Hsuan Lee, Cheng-Yuan Hsia, Yi-Hsiang Huang, Chien-Wei Su, Han-Chieh Lin, Rheun-Chuan Lee, Yi-You Chiou, Fa-Yauh Lee, Teh-Ia Huo, Performance status in patients with hepatocellular carcinoma: Determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system, Hepatology, 2013, 57, 1
  9. 9
    Y.-H. Lee, C.-Y. Hsu, C.-Y. Hsia, Y.-H. Huang, C.-W. Su, H.-C. Lin, Y.-Y. Chiou, T.-I. Huo, A prognostic model for patients with hepatocellular carcinoma within the Milan criteria undergoing non-transplant therapies, based on 1106 patients, Alimentary Pharmacology & Therapeutics, 2012, 36, 6
  10. 10
    Yun-Hsuan Lee, Chia-Yang Hsu, Cheng-Yuan Hsia, Yi-Hsiang Huang, Chien-Wei Su, Han-Chieh Lin, Che-Chuan Loong, Yi-You Chiou, Teh-Ia Huo, Defining the severity of liver dysfunction in patients with hepatocellular carcinoma by the model for end-stage liver disease-derived systems, Digestive and Liver Disease, 2012, 44, 10, 868

    CrossRef

  11. 11
    Chia-Yang Hsu, Cheng-Yuan Hsia, Yi-Hsiang Huang, Chien-Wei Su, Han-Chieh Lin, Yi-You Chiou, Rheun-Chuan Lee, Fa-Yauh Lee, Teh-Ia Huo, Shou-Dong Lee, Differential prognostic impact of renal insufficiency on patients with hepatocellular carcinoma: A propensity score analysis and staging strategy, Journal of Gastroenterology and Hepatology, 2012, 27, 4
  12. 12
    Chia-Yang Hsu, Yi-Hsiang Huang, Cheng-Yuan Hsia, Chien-Wei Su, Han-Chieh Lin, Che-Chuan Loong, Yi-You Chiou, Jen-Huey Chiang, Pui-Ching Lee, Teh-Ia Huo, Shou-Dong Lee, A new prognostic model for hepatocellular carcinoma based on total tumor volume: The Taipei Integrated Scoring system, Journal of Hepatology, 2010, 53, 1, 108

    CrossRef

  13. 13
    Teh-Ia Huo, Chia-Yang Hsu, Han-Chieh Lin, Pui-Ching Lee, Jing-Yi Lee, Fa-Yauh Lee, Ming-Chih Hou, Shou-Dong Lee, Selecting an optimal cutoff value for creatinine in the model for end-stage liver disease equation, Clinical Transplantation, 2010, 24, 2
  14. 14
    Chia-Yang Hsu, Cheng-Yuan Hsia, Yi-Hsiang Huang, Chien-Wei Su, Han-Chieh Lin, Pui-Ching Lee, Che-Chuan Loong, Jen-Huey Chiang, Teh-Ia Huo, Shou-Dong Lee, Selecting an optimal staging system for hepatocellular carcinoma, Cancer, 2010, 116, 12
  15. You have free access to this content15
    Muh-Hwa Yang, Chih-Li Chen, Gar-Yang Chau, Shih-Hwa Chiou, Chien-Wei Su, Teh-Ying Chou, Wei-Li Peng, Jaw-Ching Wu, Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma, Hepatology, 2009, 50, 5
  16. 16
    Puneeta Tandon, Guadalupe Garcia-Tsao, Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies, Liver International, 2009, 29, 4
  17. 17
    Teh-Ia Huo, Cheng-Yuan Hsia, Yi-Hsiang Huang, Han-Chieh Lin, Pui-Ching Lee, Wing-Yiu Lui, Jen-Huei Chiang, Yi-You Chiou, Che-Chuan Loong, Shou-Dong Lee, Selecting a Short-term Prognostic Model for Hepatocellular Carcinoma, Journal of Clinical Gastroenterology, 2009, 43, 8, 773

    CrossRef

  18. 18
    Chia-Yang Hsu, Yi-Hsiang Huang, Chien-Wei Su, Jen-Huey Chiang, Han-Chieh Lin, Pui-Ching Lee, Fa-Yauh Lee, Teh-Ia Huo, Shou-Dong Lee, Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Renal Insufficiency, Journal of Clinical Gastroenterology, 2009, 1

    CrossRef

  19. 19
    Yun Ku Cho, Jin Wook Chung, Jae Kyun Kim, Yong Sik Ahn, Mi Young Kim, Yoon Ok Park, Wan Tae Kim, Jong Hoon Byun, Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization, Cancer, 2008, 112, 2
  20. 20
    Teh-Ia Huo, Han-Chieh Lin, Samantha C. Huo, Pui-Ching Lee, Jaw-Ching Wu, Fa-Yauh Lee, Ming-Chih Hou, Shou-Dong Lee, Comparison of four model for end-stage liver disease–based prognostic systems for cirrhosis, Liver Transplantation, 2008, 14, 6
  21. 21
    Teh-Ia Huo, Shou-Dong Lee, Han-Chieh Lin, Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond, Liver International, 2008, 28, 5
  22. 22
    T.-I. Huo, H.-C. Lin, C.-Y. Hsia, Y.-H. Huang, J.-C. Wu, J.-H. Chiang, Y.-Y. Chiou, W.-Y. Lui, P.-C. Lee, S.-D. Lee, The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: A prospective survey, Digestive and Liver Disease, 2008, 40, 11, 882

    CrossRef

  23. 23
    Teh-Ia Huo, Yi-Hsiang Huang, Chien-Wei Su, Han-Chieh Lin, Jen-Huei Chiang, Yi-You Chiou, Samantha C. Huo, Pui-Ching Lee, Shou-Dong Lee, Validation of the HCC-MELD for dropout probability in patients with small hepatocellular carcinoma undergoing locoregional therapy, Clinical Transplantation, 2008, 22, 4
  24. 24
    Feng Zhang, Xuehao Wang, Xiangcheng Li, Lianbao Kong, Beicheng Sun, Guoqiang Li, Xiaofen Qian, Feng Chen, Ke Wang, Sheng Lu, Liyong Pu, Ling Lu, Emergency adult living donor right lobe liver transplantation for fulminant hepatic failure, Frontiers of Medicine in China, 2007, 1, 3, 282

    CrossRef

  25. 25
    Samantha C. Huo, Teh-Ia Huo, Han-Chieh Lin, Chin-Wen Chi, Pui-Ching Lee, Fan-Wei Tseng, Shou-Dong Lee, Is the Corrected-Creatinine Model for End-Stage Liver Disease a Feasible Strategy to Adjust Gender Difference in Organ Allocation for Liver Transplantation?, Transplantation, 2007, 84, 11, 1406

    CrossRef

  26. 26
    Teh-Ia Huo, Han-Chieh Lin, Cheng-Yuan Hsia, Jaw-Ching Wu, Pui-Ching Lee, Chin-Wen Chi, Shou-Dong Lee, The Model for End-Stage Liver Disease Based Cancer Staging Systems Are Better Prognostic Models for Hepatocellular Carcinoma: A Prospective Sequential Survey, The American Journal of Gastroenterology, 2007, 102, 9, 1920

    CrossRef

  27. 27
    Richard B. Freeman, The Model for End-stage Liver Disease Comes of Age, Clinics in Liver Disease, 2007, 11, 2, 249

    CrossRef

  28. 28
    TEH-IA HUO, SHOU-DONG LEE, Role of the model for end-stage liver disease and serum α-fetoprotein as prognostic predictors for hepatocellular carcinoma, Liver International, 2006, 26, 10